Dark Light

ARRS Is Your Practice Ready for the Impact of Theranostics? 2022 (CME VIDEOS)


Nuclear theranostics, combined with hybrid imaging (SPECT/CT, PET/CT, PET/MR), are playing a major role in precision medicine, significantly improving disease management—particularly in oncology. Delivered by international leaders in nuclear radiology, this comprehensive symposium on Thursday, August 11, 2022 will detail current and future roles for theranostics in imaging, particularly for patients suffering from neuroendocrine and prostate cancers.
The practice of a fully integrated diagnostic and therapeutic medical imaging specialty requires in-depth knowledge of many different fields of medicine and complex imaging equipment, alongside understanding of patient management and health care system economics. Therefore, “Is Your Practice Ready for the Impact of Theranostics?” will provide both clinical knowledge and financial tips for setting up a theranostics practice.


Session Topic

12:00 — 12:30

Theranostics: What is it?

Jean-Luc Urbain, MD, PhD

12:30 — 1:00

Precision Imaging and the Theranostics Paradigm for Radiology Practices

Andrew Scott

1:00 — 1:30

Oncology Imaging and Theranostic Applications

Homer Macapinlac, MD

1:30 — 2:00

Imaging and Treatment of Neuroendocrine Tumors

Heather A. Jacene, MD

2:00 — 2:30
Question and Answer Session

2:30 — 2:45

2:45 — 3:15

The Prostate Tsunami is Upon Us

Gholam Berenji, MD

3:15 — 3:45

Theranostics Dosimetry: Are You Serious?

Pat Zanzonico, PhD

3:45 — 4:15

The FDA Process for the Approval of Theranostics Clinic

Gang Niu, MD, PHD

4:15 — 4:45

How To Set Up Your Theranostic Clinic

Daniel Lee, MD

4:45 — 5:15

The Business Aspect of Theranostics

Reginald F. Munden, MD, DMD, MBA